Cryptococcosis is infection with Cryptococcus neoformans fungus.
Causes, incidence, and risk factors
Cryptococcus neoformans, the fungus that causes this disease, is ordinarily found in soil. It enters and infects the body through the lungs. Once inhaled, infection with cryptococcosis may go away on its own, remain in the lungs only, or spread throughout the body (disseminate).
Most cases are in people with a weakened immune system, such as those with HIV infection, taking high doses of corticosteroid medications, cancer chemotherapy, or who have Hodgkin's disease.
In people with a normal immune system, the lung (pulmonary) form of the infection may have no symptoms. In people with weakened immune systems, the cryptococcus organism may spread to the brain.
Neurological (brain) symptoms begin gradually. Most people with this infection have meningoencephalitis (swelling and irritation of the brain and spinal cord) when they are diagnosed.
Cryptococcus is one of the most common life-threatening fungal infections in people with AIDS.
Cryptococcal antigen test (looks for a certain molecule that the Cryptococcus fungus can shed into the blood)
Some infections require no treatment. Even so, there should be regular check-ups for a full year to make sure the infection has not spread. If there are lung lesions or the disease spreads, antifungal medications are prescribed. These drugs may need to be taken for a long time.
Side effects of medications (such as Amphotericin B) can be severe
Calling your health care provider
Call your health care provider if you develop symptoms of cryptococcosis, especially if you have a weakened immune system.
Take the lowest doses of corticosteroid medications possible. Practice safe sex to reduce the risk of getting HIV and the infections associated with a weakened immune system.
Kauffman CA. Cryptococcosis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 357.
David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Jatin M. Vyas, MD, PhD, Instructor in Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.